NCT04549870View on ClinicalTrials.gov

Efficacy of Roflumilast in the Treatment of Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

December 12, 2022

Study Completion Date

December 12, 2022

Conditions
Psoriasis
Interventions
DRUG

Roflumilast

Treatment according to national roflumilast guidelines

Trial Locations (1)

Unknown

Bispebjerg Hospital, Copenhagen

All Listed Sponsors
lead

Bispebjerg Hospital

OTHER

NCT04549870 - Efficacy of Roflumilast in the Treatment of Psoriasis | Biotech Hunter | Biotech Hunter